Transforming Allergy Diagnosis & Management

Everyone with allergies has probably experienced skin-prick tests and other assessments to find out exactly what they are allergic to. Today there is a new “ology” called molecular allergology that is innovating how allergies are diagnosed and treated. A routine blood test combined with molecular diagnostics will allow physicians to identify, with great specificity, the component proteins to which a patient is allergic. This new approach will also help gauge where a patient falls on the spectrum of possible reactions, so they will know what restrictions need to be put in place.

Transforming Allergy Diagnosis & Management

Physician Weekly logo

By Rebecca Rice
Apr 28, 2020

Researchers estimate that in the US, more than 50 million adults and 26 million children suffer from allergies every year, with an estimated $18 billion annually in associated costs to the healthcare system and businesses—with no end in sight, as the number of individuals affected by allergies continues to rise.

Continue Reading

Families with Food Allergies Struggle with Bare Shelves

It’s hard enough for those who have multiple food allergies to find products that are safe for them to eat, but with many grocery shelves now empty, the challenge is even greater. Read here about many families who are struggling to find the foods they know are safe due to the hoarding and stocking up by others. Please keep your fellow allergy sufferers in mind and only buy what you need. Food manufacturers are trying to keep up with the demand, and you may be able to buy directly from them if the need arises.

Families with Food Allergies Struggle with Bare Shelves

Scant offerings at a grocery store in Brooklyn last month.
Photo credit...Sarah Blesener for The New York Times

As the coronavirus spreads and locked-down communities stock up, products needed by allergy sufferers are increasingly hard to come by.

By Eric Athas
April 7, 2020

Like many Americans these days, Lisa M. Delmont is kept up at night by worry. But for Ms. Delmont, it’s the empty grocery store shelves that bring on dread.

Her 2-year-old son, Benjamin, is severely allergic to milk, eggs, cashews, pistachios and bananas, so she has to be judicious about the items she brings home. Exposure to the wrong food could send Benjamin into anaphylactic shock, something that has happened three times since he was born.

Continue Reading

FDA: Inspect Epinephrine Auto-injectors to Head Off Problem

Attention all EpiPen users! The FDA has found defects in certain models of the Epi-Pen© and is strongly urging all users to closely inspect their pens as soon as they are purchased. This article lists in detail what defects to look for, such as making sure the blue safety release is not raised and that they can remove the device easily from the carrier tube. Tips are also provided regarding user errors that prevent the device from operating properly. You can get a free replacement from Mylan if your device appears to be defective by calling the number below.

FDA: Inspect Epinephrine Auto-injectors to Head Off Problem

American Academy of Pediatrics logo

By Trisha Korioth, Staff Writer
AAP News
March 25, 2020

The Food and Drug Administration (FDA) is warning that EpiPen 0.3 mg, EpiPen Jr. 0.15 mg and the authorized generic versions of the epinephrine products may have delayed injection or be prevented from proper injection.

Continue Reading

Study: Recurring Anaphylaxis Often Follows the Same Progression in Individuals

In this helpful article, researchers report that the large majority of people who experience recurrent anaphylaxis will suffer the exact same sequence of symptoms and reactions. So if one starts to experience symptoms of an allergic reaction, they will know to seek help immediately and administer an epinephrine auto-injector (EAI) device. Medical practitioners can teach their patients to recognize their unique symptoms to allow them to earlier identify anaphylaxis and administer therapeutic interventions.

Study: Recurring Anaphylaxis Often Follows the Same Progression in Individuals

Hopscotch

By Dave Bloom SnackSafely.com
2020/03/25

In a study published in the Journal of Allergy and Clinical Immunology, researchers at the University of Toronto sought to determine whether people who suffered recurring anaphylaxis had a similar progression of symptoms each time.

Continue Reading

UPDATE: Lawsuits against Brand Name and Generic Pharma Companies Move Ahead

Are you ready to join a class action suit against “Big Pharma” for trying to monopolize the epinephrine auto-injector market? A recent ruling by a US District Judge said that numerous lawsuits against the marketers and manufacturers of epinephrine auto-injectors may proceed as a nationwide class-action under a federal racketeering statute. Both brand name and generic drug companies allegedly tried to eliminate competition so they could raise prices by 500% or more. This ruling allows all persons and entities in the US who paid or provided reimbursement for Epi-Pens© as of August 24, 2011, to sue for damages under the federal Racketeer Influenced and Corrupt Organization (RICO) Act. Stay tuned for more details as they become available.

Mylan CEO Heather Bresch testifies before a U.S. House of Representatives Committee

Ruling Allows Millions to Join Lawsuit in Epi-Pen© Racketeering Case

By Dave Bloom
SnackSafely.com
2020/02/28

US District Judge Daniel Crabtree ruled yesterday that numerous lawsuits against the marketer and manufacturer of Epi-Pen© may proceed as a nationwide class-action under a federal racketeering statute. His ruling also allows consumers to sue for damages under state antitrust laws.

Continue Reading

The information provided on this site is in no way intended to be a substitute for medical advice,
diagnosis, or treatment with a licensed physician.
The Allergy Advocacy Association is a 501(c)(3) non-profit, tax-exempt organization.
Copyright 2020 © Allergy Advocacy Association, Inc. All rights reserved.  Terms & Conditions